Myasthenia gravis constitutes chronic autoimmune ailment that primarily impacts the neuromuscular junction. This junction facilitates the transfer of signals from nerves to muscles, enabling movement. In myasthenia gravis, the body's immune system erroneously attacks these receptors, resulting weakness and fatigue in the motor units. The indicatio